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FLORIDA SUPREME COURT
UPHOLDS ADEQUACY OF
PRODUCT WARNINGS
REGARDING ACCUTANE
In Felix v. Hoffmann-LaRoche, Inc., 540 So. 2d
102 (Fla. 1989), the Supreme Court of Florida
held that while the adequacy of a product warning provided by a manufacturer is usually a question of fact for the jury, adequacy may become a
question of law where the warning is accurate,
clear and unambiguous. The court held that the
warnings accompanying Accutane which were
addressed to physicians rather than patients
were adequate and were not the proximate
cause of the wrongful death of a patient's child.
Background
Accutane is a drug usually prescribed for
severe and disfiguring cases of acne.1 It was
approved for sale in this country by the United
States Food and Drug Administration ("the FDA")
in 1982. At that time, Hoffmann-LaRoche, Inc.,
("Hoffmann-LaRoche") began manufacturing
and selling Accutane in the United States. Late in
1982, Yolanda Felix went to a physician, Dr.
Greenwald, for treatment of a persistent and
prolonged cystic acne condition of her face and
shoulders. Greenwald prescribed Accutane,
then considered a "miracle drug" for acne
treatment. Felix was pregnant at the time she
received the prescription. Greenwald claimed
that he warned Felix against the use of Accutane
during pregnancy, but Felix denied receiving
any such warning. Greenwald admittedly knew
of the product's teratogenicity,2 because he
independently had researched the side effects
of the drug and had attended seminars regarding Accutane's dangers. Greenwald was also
aware of the warnings accompanying the drug.
These warnings recommended that the drug not
be used during pregnancy.
Felix subsequently gave birth to a child with
severe birth defects. She attributed the birith
defects and premature death of her child to her
ingestion of Accutane during pregnancy. Consequently, she filed a lawsuit against HoffmannLaRoche for the wrongful death of her child. She
alleged that the failure of Hoffmann-LaRoche to
furnish adequate warnings about the dangerous
effects of consuming Accutane during pregnancy had caused the death of her child.

The trial court rejected Felix's contention and
entered summary judgment in favor of Hoffmann-LaRoche. The appellate court affirmed
the lower court's judgment for two reasons.
First, the appellate court reasoned that Hoffmann-LaRoche's warnings were adequate as a
matter of law and second, even if the warnings
were inadequate, they were not the proximate
cause of the child's birth defects and death
because Greenwald knew of the teratogenicity
of the product.
Supreme Court: Adequacy of Warnings May Be
a Question of Law
On appeal to the supreme court of Florida,
Felix argued that the adequacy of a drug warning is always a question of fact for the jury and
can never be decided as a matter of law. Felix
relied upon several Florida cases to support her
argument. In response, Hoffman n-LaRoche contended that making the adequacy of a drug
warning solely a question of fact for the jury
would hamper product development and marketing. The supreme court rejected Felix's argument, thus deviating from the precedent set by
lower courts. The court stated that questions
relating to the adequacy of product warnings
will be questions of law when the warnings are
accurate and clear.
The supreme court noted that because physicians were to serve as " 'learned intermediar[ies]' between the manufacturer and the consumer," 540 So. 2d at 104, Hoffmann-LaRoche
properly directed the warnings about Accutane's dangers to physicians and not to consumers. Hoffmann-LaRoche thus had no duty to
warn consumers directly of the product's dangers. According to the court, the language used
in the warnings, though technical, was undoubtedly familiar to those in the medical profession and clearly defined the risks of Accutane.
The warnings reported that no reliable studies
had been conducted on pregnant women ingesting Accutane but that studies conducted on rats
and rabbits revealed that animals exposed to the
drug suffered teratogenic side effects. Based on
these observations in animals, the warnings cautioned that pregnant women should not receive
Accutane. The warnings also recommended that
women of childbearing years use an effective
form of contraception while undergoing Accutane therapy.
(continued on page 106)
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At the time Felix ingested Accutane, these
warnings were accurate. Documented cases of
Accutane-related teratogenicity in human fetuses and offspring appeared only after Felix had
ingested Accutane. The language used in the
warnings thus contained no misrepresentations
that would mislead a physician prescribing the
drug. For these reasons, the Supreme Court held
the warnings were comprehensive, clear, and
accurate. Thus, the court affirmed the judgement of the appellate court.
Warnings Not Proximate Cause of Infant's Death
The supreme court similarly adopted the reasoning of the appellate court that, although
Greenwald's alleged failure to share his knowledge of the dangers of Accutane with Felix
might be important in a claim against the doctor
himself, such was irrelevant in a liability action
against the manufacturer Hoffmann-LaRoche.
Both courts observed that the manufacturer
could not be held liable for a doctor's failure to
impart knowledge to a patient.

IOWA SUPREME COURT HOLDS
INSURANCE COVERAGE IS
UNAVAILABLE IF UNIDENTIFIED
HIT AND RUN DRIVER
DOES NOT PHYSICALLY
CONTACT VICTIM
In Moritz v. Farm Bureau Mut. Ins. Co., 434
N.W.2d 624 (Iowa 1989), the Iowa Supreme
Court ruled that the "uninsured motorist" clause
of an automobile insurance policy does not
apply when there is no physical contact between
the insured car and a vehicle which is claimed to
have caused the accident. Reasoning that insurance companies must be protected from fraudulent claims, the court held that the companies
need not provide coverage when there is no
physical contact between the insured car and
the unidentified vehicle. In addition, the court
held that the doctrine of reasonable expectations, which requires that insurance policies be
construed as the insured layperson would construe them, was properly considered and re-
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The supreme court concluded that the death
of Felix's child could not be attributed to an
inadequacy in the warnings because the warnings were adequate at the time Greenwald prescribed the drug to Felix. Moreover, HoffmannLaRoche had only the duty to warn the prescribing physician of the drug's dangers unless the
FDA stipulated otherwise. Because HoffmannLaRoche had fulfilled its duty, it could not be
held liable.
Elizabeth A. Mitchell
1.

Accutane, derived from Vitamin A, falls within a class of drugs
known as retinoids. Since 1954, retinoids have been known to
cause birth defects in children whose mothers ingested them in
large doses during pregnancy. Patients taking Accutane suffer
side effects which include loss of vision, severe depression, gastrointestinal and cardiac problems, and central nervous system
disorders. See Nygaard, Accutane: Is the Drug a Prescription for
Birth Defects?, 24 TRIAL 81 (1988).
2. Teratogenicity is defined as the ability to create a deformed,
abnormal being. Accutane's teratogenicity was first noted by Dr.
Wener Bollag of Hoffmann-LaRoche's parent company. Bollag
compared Accutane's effects to those of thalidomide, the highlypublicized tranquilizer that was withdrawn from the market in
the 1960s because it caused severe limb deformities in the children of mothers who had used the drug. Id.

jected by the lower court. Finally, the court
rejected the plaintiff's claims that Iowa's uninsured motorist statute, Iowa Code Ann. 516A.1516A.4 (West 1988) ("the Act"), violates the equal
protection clauses of the Iowa and the United
States Constitutions.
Background
In September, 1986, Michaela Moritz (Moritz)
was a passenger in a car that was forced off the
road by an unidentified driver of another vehicle. The car ran into a tree and Moritz was
injured. Moritz brought suit against the Farm
Bureau Mutual Insurance Company ("Mutual
Insurance"), the insurer of the car in which she
was riding, to recover for her injuries under the
policy's "uninsured motorist" clause. Two counts
of her complaint alleged that Mutual Insurance
was liable for Moritz' injuries caused by the unidentified driver of the other vehicle. In its
motion for summary judgment, Mutual Insurance maintained that collisions caused by unidentified motorists were covered only when
there was physical contact between the un-

